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It is known that COUP-TFI and COUP-TFII can act as transcriptional repressors or activators, and the role of COUPTFs in metabolism has been examined in tissues such as liver and adipose tissue.
In liver cells, COUP-TFII stimulates CYP7A (33, 37, 73) and CETP transcription (20) , and represses apolipoprotein AI expression (38) , demonstrating a role for COUP-TFII in the regulation of cholesterol homeostasis in liver. Also in HepG2 cells, COUP-TFI inhibits transactivation of the CPT-II promoter by PPAR␣/RXR␣, and is required for stimulation of phosphoenolpyruvate carboxykinase 1 (PEPCK) by dexamethasone (27) , which plays a large role in regulation of gluconeogenesis in the liver.
Studies on the role of COUP-TFII in adipose tissue development and energy metabolism have given conflicting results. For example, Li et al. (45) demonstrated an essential role for COUP-TFII in white adipose tissue development, while other studies report that COUP-TFII is a suppressor of adipogenesis (57, 81) .
In vivo studies have indicated that among other demonstrated physiological roles, COUP-TFs play a role in metabolism. Insulin represses COUP-TFII expression in pancreas and liver of mice (61) and loss of COUP-TFII expression in pancreatic beta cells in mice led to abnormal insulin secretion, glucose intolerance, and peripheral insulin resistance (5) . Paradoxically, mice globally haploinsufficient for COUP-TFII have improved glucose homeostasis and increased energy expenditure, resistance to high fat diet-induced obesity and insulin resistance, and less white adipose tissue mass (45) . Furthermore, COUP-TFI and COUP-TFII expression was reduced in white adipose tissue of rats fed a high-fat diet (57) , and expression levels of COUP-TFII mRNA and protein were lower in the livers of ob/ob mice than in their lean ob/ϩ littermates (61) , further indicating a role for COUP-TFII in glucose and lipid metabolism.
The role of COUP-TFs in skeletal muscle has been less well characterized. Skeletal muscle is a peripheral tissue that accounts for ϳ40% of the total body mass and of fuel expenditure and is a major site of fatty acid and glucose metabolism. Moreover, this major mass tissue secretes cytokines that control muscle mass, energy balance, and fat deposition. Consequently, muscle has an important function in insulin sensitivity, glucose tolerance (69) , the serum lipid profile, and energy homeostasis. Accordingly, this contractile tissue plays a substantial role in the sequence of events involved in dyslipidemia, diabetes, and obesity, which are major risk factors for cardiovascular disease.
Previous work investigating the role of COUP-TFs in metabolism in skeletal muscle demonstrated that attenuation of COUP-TFI and COUP-TFII in the C2C12 in vitro cell culture model modulated metabolic gene expression and specifically LXR-dependent gene regulation (54) . While this study demonstrated a role for COUP-TFs in skeletal muscle metabolism, the individual roles for COUP-TFI and COUP-TFII in skeletal muscle were not elucidated, as both COUP-TFI and COUP-TFII were attenuated.
In the current study we have examined the effect of overexpression of ectopic COUP-TFII in skeletal muscle. Using Taqman Low Density Array (TLDA) rigorous quantitative (q)PCR analysis, we examined downstream gene targets of COUP-TFII in stable C2C12 cell lines overexpressing ectopic COUP-TFII. Given the significant role of skeletal muscle in glucose modulation, we chose the physiologically relevant target gene, glucose transporter type 4 (Glut4), for further analysis. Ectopic expression of helix 12 truncated COUP-TFII (COUP-TFII⌬H12), which has been demonstrated to lack activation and repression of target genes (1, 36) , led to decreased Glut4 mRNA expression in C2C12 cells, further confirming COUP-TFII regulation of Glut4. Using chromatin immunoprecipitation (ChIP) analysis, we demonstrated binding of COUP-TFII to the Glut4 promoter in C2C12 cells. Similarly, using promoter assays we found that COUP-TFII activates the Glut4 promoter through a highly conserved SP1 site in skeletal muscle C2C12 cells.
MATERIALS AND METHODS
Cell culture. Mouse C2C12 skeletal muscle cells were cultured and maintained in growth medium (DMEM supplemented with 10% heat-inactivated Serum Supreme; Cambrex Bioscience, Victoria, Australia) in 6% CO 2. Differentiation into postmitotic multinucleated myotubes was induced by 4 -5 days of serum withdrawal [DMEM supplemented with 1% horse serum (Trace Scientific Pty.) and 1% heat inactivated Serum Supreme] for 4 days.
Plasmids. Glut4 promoter 1.8 kb upstream of transcription start site was first cloned by PCR using the primers TTT TAC GCG TGG GTT AAT AGA AGA GAG CCA CC and TTT TCT CGA GAG TGA GAC CCG CTT GAG GGG GA and ligated into PCR-script from mouse skeletal muscle. The Glut4 promoter fragment was then subcloned into pGL2basic after excision with MluI and XhoI. pGL2-Glut4 was further mutated by QuickChange PCR site-directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. The oligonucleotides used were Glut4m1F: GGG CTA GGG GTG GGG TTT TGG CCT TTT GGG GTG and Glut4m1R: CAC CCC AAA AGG CCA AAA CCC CAC CCC TAG CCC. The sequences were verified by sequencing.
Animals. RNA from skeletal muscle tissues described and characterized in Pearen et al. (60) were utilized for the qPCR analysis of COUP-TFI and II mRNA expression in soleus, tibialis anterior, and plantaris. Male C57BL/10 ScSn (C57BL/10, wild type, 6 -7 wk old) were obtained from the Animal Resource Centre (Canning Vale, WA, Australia).
Generation of C12C2 stable COUP-TFII cell lines. C2C12 cells were transfected at 50% confluence with 1.9 g of expression vector (pSG5-COUP-TFII or pSG5) and 0.1 g CMV-NEO per well of a six-well plate, using Lipofectamine 2000 (Invitrogen) as indicated by the manufacturer. The following day the transfectants were passaged into three independent polyclonal pools, and cells were selected over 8 -12 days with 600 g/ml G418 in growth medium. Following the selection process and the death of the nontransfected control population, viable stable cell populations were maintained in growth medium supplemented with 300 g/ml of G418. Transfection and selection were also performed using pSG5-COUP-TFII⌬H12, expressing COUP-TFII amino acids 1-388, lacking helix 12. Each independent stable myoblast pool was grown in DMEM supplemented with 10% heat-inactivated Serum Supreme in 6% CO2. The lines were differentiated into myotubes (postmitotic multinucleated cells) by culturing in DMEM supplemented with 1% heat-inactivated Serum Supreme and 1% horse serum in 6% CO 2 for 4 days/96 h (and denoted as MT4, myotube day 4). Differentiated myotubes were analyzed on a Nikon Eclipse TS100 microscope (Coherent Scientific, SA, Australia) and digital images were captured on a Nikon Coolpix 4500 digital camera.
RNA extraction and cDNA synthesis. RNA from proliferating myoblasts (PMB) and myotubes (after 4 days of mitogen withdrawal) was extracted from C2C12 cells using TRI-Reagent (Sigma-Aldrich, Castle Hill, Australia) according to the manufacturer's protocol. Extracted RNA was treated with 2 U Turbo DNase (Ambion, Austin, TX) for 30 min. RNA was further purified using a mini-RNeasy kit (QIAGEN, Valencia, CA) according to the manufacturer's instructions. cDNA was synthesized from 2 g of total RNA using Superscript III primed by random hexamers, according to the manufacturer's instructions (Invitrogen, Carlsbad, CA).
TLDA analysis. Custom-designed ABI microfluidic TLDAs were used in a reverse transcriptase polymerase chain reaction (RT-PCR) process using the ABI Prism 7900 HT Sequence Detection System (Applied Biosystems). Two sets of TLDAs were used in this study, one designed to contain Gene Expression Assays to measure mRNA levels of 48 members of the mouse Nuclear Receptor superfamily, 43 key metabolic genes involved in myogenic and lipogenic pathways. The second TLDA contains genes involved in metabolism (lipid, carbohydrate, and energy homeostasis). Five control genes were utilized, 18S rRNA, Gapdh, Hprt1, GusB, and 36b4/Arbp to span the relative abundance/Ct range of the genes on the card. A total of 100 l reaction mixture with 50 l cDNA template (116 ng)(synthesized from the differentiated RNA, characterized in Fig. 2B ) and an equal volume of TaqMan universal master mix (Applied Biosystems) was added to each port of TLDA after gentle pipetting to mix. Thermal cycler conditions were as follows: 2 min at 50°C, 10 min at 94.5°C and 30 s at 97°C, and 1 min at 59.7°C for 40 cycles and thermal cycling and fluorescence detection was performed on Applied Biosystems ABI Prism 7900HT Sequence Detection System with ABI Prism 7900HT SDS Software 2.1. The threshold cycle Ct was automatically given by RQ manager. Relative quantification (RQ) between different sample groups were determined using the equation: RQ ϭ 2 Ϫ ⌬⌬Ct and statistical analyses for the TLDAs were analyzed using the Integromics StatMiner software package (ABI).
In brief, significant changes in expression were analyzed using the ABI/integromics StatMiner software package. Differentially expressed genes were identified by Linear models (contained in the LIMMA package for Bioconductor R embedded in StatMiner). Significance is assigned by the application of the Empirical Bayes statistic, described as equivalent to shrinkage of the estimated sample variances toward a pooled estimate, resulting in far more stable inference when the number of arrays is small. It returns the empirical Bayes log odds of differential expression, (i.e., the probability) that a gene is differentially expressed (a higher score represents a more significant result). For example, B statistic of zero indicates a 50:50 chance of differential expression, B scores Ͼ0 indicate Ͼ50:50 chance of differential expression, B Ͻ0 (-ve scores) reflect odds that a gene is more than likely, not differentially expressed. The B-statistic considers and ranks a proportion of differentially expressed genes (P Ͻ 0.01). Analysis also includes t, the empirical Bayes moderated t-statistic (a variant t-test), an empirically moderated estimate of standard error (25, 70) .
qRT-PCR. Target cDNA levels were compared by qRT-PCR in 25 l reactions containing 1ϫ SYBR green (Applied Biosystems, Foster City, CA), 100 nM of each forward and reverse primers and the equivalent of 0.3 l cDNA. Using an ABI Prism 7500 sequence detection system (Applied Biosystems), PCR was conducted over 45 cycles of 95°C for 15 s and 60°C for 1 min, preceded by an initial step 95°C for 10 min. Results were normalized against 36B4 and compared by relative expression.
Expression of ectopic COUP-TFII was determined using the primers: ectopic COUPII F: GTTATTGTGCTGTCTCATCATTTTGG, ectopic COUPII R: GCTGACTACCATTGCCATGAATT.
Luciferase assays. Proliferating C2C12 myoblasts were grown 24-well plates to 40 -50% confluence. Cells were transiently trans-fected with reporter and receptor expression plasmids using DOTAP and Metafectene (Biontex Laboratories, Munich, Germany) liposome mixture in 1ϫ HEBS [HEPES-buffered saline (42 mM HEPES, 275 mM NaCl, 10 mM KCl, 0.4 mM Na 2HPO4, 11 mM dextrose, pH 7.1)]; 16 -24 h later, fresh cell culture medium was added, and cells were harvested 24 h later. Luciferase assays were performed using the LucLite luminescence reporter gene assay system as outlined by the manufacturer (PerkinElmer Life Sciences). Luminescence was recorded on a MicroBeta luciferase system (PerkinElmer Life Sciences). All experiments were repeated at least three times in triplicates.
Protein extraction. Total soluble protein was extracted from three additional stable lines of COUP-TFII transfected cells, by the addition of lysis buffer (10 mM Tris, pH 8.0; 150 mM NaCl; 1% Triton X-100; 5 mM EDTA) containing protease "cocktail" inhibitors (SigmaAldrich). Lysates were passed through a 26-gauge needle and centrifuged at 10,000 rpm for 20 min. The supernatant was collected and total protein concentration was determined by the BCA as outlined by the manufacturer's instructions (Pierce Biotechnology, Rockford, IL).
Western blot. Total soluble protein was separated by SDS 10% polyacrylamide gel electrophoresis and transferred to PVDF membrane. The membranes were blocked for 1 h in 5% skim milk in Tris-buffered saline/Tween 20, followed by overnight incubation at 4°C with COUP-TFII (Santa Cruz), Glut4 (Abcam) or GAPDH (R&D Systems, Minneapolis, MN) antibodies and incubated with anti-rabbit, anti-goat or anti-mouse horseradish peroxidase for 2 h. Immunoreactive signals were detected using Amersham ECL Plus Western Blotting detection system and visualized by autoradiography on an XOmat film developer (Kodak). The Western blot(s) in Fig. 2D on COUP-TFII expression during myogenesis were performed on another set of three independently transfected/selected polyclonal stable cell line, with independently validated ectopic and total COUP-TFII mRNA expression.
ChIP assay. C2C12 cells were grown to confluence and subsequently differentiated for 5 days.
Cells were washed with PBS and cross-linked with 1% formaldehyde at room temperature for 10 min. ChIP was performed as previously described by Shang et al. (68) using 5 mg of anti-COUP-TFII polyclonal antibody (Santa Cruz Biotechnology) or as negative controls 5 mg of goat IgG (Santa Cruz Biotechnology). The DNA was purified using QIAquick Spin Kit according to the manufacturer's instructions (Qiagen) and ChIP samples were analyzed using qRT-PCR using the following primers, designed to detect occupancy of three regions encompassing SP1 binding sites, as determined by Matinspector analysis of the Glut4 promoter -Glut4 Upstream F: TCTCTCTCCACATTCTTCGCC, Glut4 Upstream R: GCGA-CAAGCTTTCCAGAGTCA, Glut4 site A F: GGAACGGAAGT-TATTGGTCCC, Glut4 site A R: ACGTTAGGCTCCGCCAAAT, Glut4 site B F: AGCCTTTTGTTCCAAGGACCC, Glut4 site B R: AAAGATGCGGAGAGCTGAAGC, Glut4 site C F: TCAC-TAGATCCCGGAGAGCCTT, Glut4 site C R: TTCGGAAGCCGT-GTGCAAA.
The ChIP assays were carried out three times, and values are expressed as average fold enrichment over IgG controls, from the three individual experiments.
RESULTS
Ectopic expression of COUP-TFII in stable skeletal muscle cell line. As discussed in the introduction, previous studies demonstrated that attenuation of COUP-TF (I and II) in the C2C12 in vitro cell culture model modulated metabolic gene expression (54) . However, the study did not address the specific roles for COUP-TFI and COUP-TFII in skeletal muscle cells, as both COUP-TFI and COUP-TFII were attenuated.
To address this issue in a physiologically relevant context, we examined the relative expression of COUP-TF I and II mRNA, in soleus and plantaris (and anterior tibialis) tissue, representative of slow and fast twitch skeletal muscle fibers in C57BL/10 mice, respectively. We observed that COUP-TFII mRNA was Ͼ10-fold more abundant than COUP-TF I mRNA in (type I and II) skeletal muscle tissue (Fig. 1A) . Secondly, and in concordance with the in vivo expression profile, COUP- TFII was clearly more abundantly expressed than COUP-TFI mRNA in skeletal muscle cells (Fig. 1B) .
Consequently, we examined and focused on investigating the effects of ectopic COUP-TFII expression on NR, metabolic, and myogenic gene expression in an in vitro cell culture system after stable transfection.
C2C12 cells were transfected with either the vector only (pSG5), or pSG5-COUP-TFII (see MATERIALS AND METHODS). The stable cell lines were validated by examining ectopic/ exogenous and total (endogenous ϩ ectopic) COUP-TFII mRNA expression in the stable (G418 selected) cell lines with qPCR using primers to a region spanning the beta-globin intron (from the pSG5 expression vector) and the 5=-region of the COUP-TFII gene, expressed by the pSG5-COUP-TFII vector ( Fig. 2A) . RNA was extracted from PMB and differentiated myotubes (after 4 days of serum withdrawal, MT4) and ectopic and total COUP-TF mRNA expression determined. Ectopic/ Exogenous and total (ectopic ϩ endogenous) COUP-TFII mRNA expression were detected in (PMB and MT4) from each of the COUP-TFII-transfected cell lines (pSG5-COUP-TFII-1, pSG5-COUP-TFII-2, and pSG5-COUP-TFII-3), and as expected, no exogenous COUP-TFII expression was detected in the pSG5 (vector) transfected cells (pSG5-1, pSG5-2, and pSG5-3) (Fig. 2, B and C) . We observed elevated expression of COUP-TFII protein in proliferating and confluent myoblasts growing in DMEM supplemented with 10% heat-inactivated Serum Supreme in 6% CO 2 . However, serum/growth factor withdrawal-mediated induction of differentiation into postmitotic multinucleated cells resulted in the downregulation of COUP-TFII protein expression that occurs during normal myogenesis in culture (Fig. 2D ). This suggested that COUP-TFII protein expression was regulated in a posttranscriptional manner. Relative expression of ectopic (B) and total COUP-TFII mRNA (C) in proliferating myoblasts (PMB) and myotubes from the pSG5 and COUP-TFII-transfected C2C12 stable cell lines. Western blot analysis of COUP-TFII protein in stable pSG5, and pSG5-COUP-TFII transfected C2C12 myoblasts and myotubes (D). This is an analysis of 1 polyclonal line (and representative of Western analysis of 2 other polyclonal lines). Total protein from PMB, confluent myoblasts (CMB), and days 1, 2, 3, and 4 of differentiation were analyzed by Western blot. GAPDH was used as a loading control.
In summary, these experiments demonstrate that the polyclonal pools of stable myogenic C2C12 cells ectopically express COUP-TFII mRNA and protein (in a differentiationdependent manner).
Ectopic COUP-TFII expression in C2C12 cells markedly regulates expression of nuclear receptors. We performed rigorous qPCR analysis utilizing a custom designed ABI microfluidic TLDA. This TLDA encoded TaqMan primer sets targeting the entire (i.e., 48) NR superfamily involved in the pathophysiological control of development, reproduction, endocrine physiology. and organ-specific metabolism. These TLDAs also include five normalization controls: 18S rRNA, GAPDH, Gusb, HPRT, and 36B4. The 18S rRNA, GAPDH, and 36B4 have been utilized by the Nuclear Receptor Signaling Atlas consortium.
Specifically, TLDA analysis of the three stable (independent polyclonal) cell lines transfected with vector (pSG5) alone, and pSG5-COUP-TFII (after 96h/4 days of serum withdrawal induced differentiation) revealed the significant differential expression (assigned by the Empirical Bayes statistic) when normalized against the statminer v3-Genorm selected controls (Gusb and HPRT) of the mRNAs encoding several nuclear receptors (Fig. 3A) .
The nuclear receptors androgen receptor (AR), testicular receptor 2 (Nr2c1), glucocorticoid receptor (Nr3c1), PPAR gamma (Pparg), Rorb, and Rorc were downregulated in the COUP-TFII stable cell lines (normalized to the Genorm selected control) 5-to 50-fold (0.5-1.5 Log10-RQ), relative to the pSG5 (vector only) transfected line (Fig. 3A, Table 1 ). Moreover, ER␤ (Esr2), ERR gamma (Esrrg), and RXR gamma Tables 1-3 , respectively, expressed as fold changes normalized to the mean of Genorm-selected controls. Differentially expressed genes were identified by Linear models (contained in the LIMMA package for Bioconductor R embedded in StatMiner). The Relative Quantification Log10, i.e., the calculated fold differences [between the target (in the COUP-TFII cells) and the calibrator/reference (vehicle treatment) sample] are displayed in Tables 1-3, respectively. Data are presented as valid, when the Ct values of the gene in the calibrator/reference and target samples (i.e., SG5 and SG5-COUP-TFII-transfected cells, respectively) are Ͻ35 cycles. Moreover, fold differences are flagged as target not detected, calibrator not detected, and no detection, when the Ct value of the gene(s) in the target (COUP-TFII transfected), calibrator (pSG5 transfected), and/or both samples are 35 cycles or greater (than the threshold limit). Hence, the reported quantitative "fold change of a gene that is not expressed in some of the biological conditions may not be reliable" (47) ; however, it does reflect a qualitative difference. Significance is assigned after the application of the empirical Bayes statistic are considered for the final assignments (see MATERIALS AND METHODS): *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001.
(RXRg) were increased markedly, 10-to 100-fold (1.0 -2.0 Log10-RQ) (Fig. 3A, Table 1 ) in the COUP-TFII-transfected C2C12 cell lines. This demonstrated that the elevated level of COUP-TFII protein in the proliferating and confluent myoblasts modulate the NR expression profile.
Ectopic COUP-TFII expression in C2C12 cells strikingly regulates expression of several metabolic genes. We utilized qPCR analysis and another custom designed ABI microfluidic TLDA that encoded Taqman primer sets for 91 critical metabolic genes that control fatty acid, glucose, and energy metabolism to determine if COUP-TFII similarly modulates the expression of these genes. These TLDAs also include five normalization controls: 18S rRNA, GAPDH, Gusb, HPRT1, and 36B4.
Specifically, TLDA analysis of the three stable (independent polyclonal) cell lines transfected with vector (pSG5) only, and pSG5-COUP-TFII revealed the significant differential expression (assigned by the Empirical Bayes statistic) when normalized against the statminer v3-Genorm selected controls (Gusb and HPRT1) of the mRNAs encoding several critical metabolic genes.
For example, we observed a significant increase (3-to 6-fold) in the expression of the mRNAs encoding Akt-1, Caveolin 3 (Cav3), glycogen synthase (Gys1), NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 (Ndufb5), PGC1␣ (Ppargc1a), muscle glycogen phosphorylase (Pygm), Glut4 (Slc2a4), and UCP2 in the COUP-TFII (relative to vector only)-transfected lines (Fig. 4, A and B; Table 2 ). In contrast, the mRNAs encoding Acsl4, Akt3, Hif1a, Lipase C (LipC), Ppm2c, Rock1 and Rock2, Scd1, and Sirt1 were downregulated (5-to 10-fold) in the COUP-TFII (relative to vector only)-transfected lines (Fig. 4, A and B; Table 2 ). Ectopic COUP-TFII expression in C2C12 cells distinctly regulates expression of myogenic genes. We further exploited qPCR analysis on the TLDA platform that encoded TaqMan primer sets for ϳ48 critical myogenic genes that control muscle contraction, muscle-specific transcription, muscle mass, and myogenic-specific cytokines. These TLDAs includes the five normalization controls: 18S rRNA, GAPDH, Gusb, HPRT1, and 36B4.
TLDA analysis of the cell lines transfected with vector (pSG5) alone and pSG5-COUP-TFII revealed the significant differential expression (assigned by the Empirical Bayes statistic) when normalized against the statminer v3-Genorm selected controls (Gusb and HPRT1) of the mRNAs encoding several important muscle-specific genes.
For example, we demonstrated the attenuation of mRNAs encoding the myogenic genes Acvr2a, Arnt1, Hdac2, Hdac9, Il15, myostatin (Mstn), Myod1, Smad2, Smad4, Smurf1, and Tgfbr1 (0.5-1.5 Log10RQ) in the COUP-TFII-transfected, relative to the pSG5-transfected control cell lines (normalized against the Genorm selected) (Fig. 3B, Table 3 ).
COUP-TFII regulates GLUT4 (mRNA and protein) expression. Given skeletal muscle has a significant role in the modulation of glucose uptake, we decided to further examine and validate the patho-physiologically relevant gene Glut4 (Slc2a4), which was identified by TLDA analysis as a downstream target of COUP-TFII signaling in skeletal muscle.
Figures 4B and 5A show that Glut4 mRNA was significantly expressed ϳ3-fold higher in the ectopic COUP-TFII-trans- Tables 1-3 , respectively, expressed as fold changes normalized to the mean of Genorm selected controls. Differentially expressed genes were identified by Linear models (contained in the LIMMA package for Bioconductor R embedded in StatMiner). The Relative Quantification Log10, i.e., the calculated fold differences [between the target (in the COUP-TFII cells) and the calibrator/ reference (vehicle treatment) sample] are displayed in Tables 1-3 , respectively. Data are presented as valid, when the Ct values of the gene in the calibrator/reference and target samples (i.e., SG5 and SG5-COUP-TFIItransfected cells, respectively) are Ͻ35 cycles. Moreover, fold differences are flagged as target not detected, calibrator not detected, and no detection, when the Ct value of the gene(s) in the target (COUP-TFII transfected), calibrator (pSG5 transfected), and/or both samples are 35 cycles or greater (than the threshold limit). Hence, the reported quantitative "fold change of a gene that is expressed in some of the biological conditions may not be reliable" (47); however, it does reflect a qualitative difference. Significance is assigned after the application of the empirical Bayes statistic are considered for the final assignments (see MATERIALS AND METHODS), *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001. 
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fected cell lines compared with the vector control pSG5-transfected cell lines when analyzed by TLDA and manual Sybr real-time PCR, normalized to GAPDH. Interestingly, the differentiation-dependent expression of the Glut4 mRNA was maintained in the COUP-TFII-transfected cells. Western blot analysis of the three independent polyclonal lines demonstrated that Glut4 protein levels were elevated in the COUP-TFIItransfected C2C12 myotubes compared with the pSG5 control vector-transfected cells (Fig. 5B) .
We similarly transfected and selected several polyclonal cell lines expressing pSG5-COUP-TFII⌬H12. Deletion of helix 12 from the COUP-TFII ligand binding domain has been demonstrated to impair the function of this orphan receptor. Previous reports have shown helix 12 was necessary for activation and silencer functions of COUP-TFs (13, 34, 35, 38, 50, 51, 66, 77) . Figure 5C demonstrates by Western blot the migration of the ectopic native (which was ϳ50 kDA) and truncated COUP-TFII proteins. Analysis of one polyclonal line expressing the most abundant level of ectopic COUP-TFII⌬H12 (Fig. 5D ) and displaying decreased total COUP-TFII mRNA (Fig. 5D ) and concomitantly decreased COUP-TFII protein levels in (proliferating and confluent) myoblasts (Figs. 5F ) demonstrated that the expression of COUP-TFII⌬H12 decreased Glut4 mRNA levels (Fig. 5E ). This demonstrated that COUP-TFII expression was necessary for Glut4 mRNA expression.
COUP-TFII trans-activates the Glut4 promoter: COUP-TFII is directly recruited to the promoter.
To determine whether COUP-TFII activates the Glut4 promoter in C2C12 cells, promoter assays were carried out using a Glut4 luciferase reporter (Ϫ997 -ϩ3 Glut4LUC). Transient cotransfection of the COUP-TFII expression vector with the Glut4 promoter significantly trans-activated the Glut4 promoter (Ͼ5-fold, P Ͻ 0.001) (Fig. 6A) .
Matinspector analysis of the Glut4 promoter was performed to scan the promoter for potential COUP-TF binding sites.
While Matinspector analysis detected no COUP-TF binding sites in the Glut4 promoter, many Sp1 sites were detected. As it has recently been demonstrated that COUP-TF upregulates the NGF1 promoter through an Sp1 site (62), primers were designed to encompass three regions spanning Sp1 sites in the Glut4 promoter (Fig. 6B) , as well as an upstream region lacking any COUP-TF or Sp1 sites. ChIP analysis was carried out to determine whether COUP-TFII binds any of these regions in C2C12 cells.
Primers were designed to three regions of the Glut4 promoter, each encompassing Sp1 binding sites and designated site A, site B, and site C. ChIP analysis demonstrated COUP-TFII binding to the Glut4 promoter region denoted site B (Fig.  6, B and C) . Binding of COUP-TFII was 144.6-fold higher than binding of IgG in this region, while fold enrichment of COUP-TFII over IgG was 4.881 at site A, 2.11 at site C, and 0.404 at the upstream region analyzed.
This region designated site B in the ChIP analyses encompasses a highly conserved Sp1 region among human, rat, and mouse promoter sequences (Fig. 6D) . Moreover, a role for this site has been implicated in insulin induced upregulation of Glut4 in adipocytes (29) .
Mutation of this Sp1 site (in the Glut4 promoter) (Fig. 6D ) resulted in the ablation of COUP-TFII mediated trans-activation of the Glut4 promoter (Fig. 6A) . These experiments demonstrated that recruitment of COUP-TFII to the highly conserved Sp1 site in the GLUT4 promoter was involved in the transcriptional regulation of this gene.
DISCUSSION
This study has identified novel gene targets of the COUP-TFII signaling in skeletal muscle cells, involved in metabolic and differentiation pathways in C2C12 cells. Previously it was shown that siRNA mediated attenuation of both COUP-TFI and COUP-TFII in C2C12s-mediated changes in expression of several metabolic genes and nuclear receptors. These gene targets included genes involved in fatty acid homeostasis (Ppar␣, Fabp3, and Cpt-1) energy expenditure and balance (Ucp1 and Ucp3) and lipid efflux (Abca1 and Abcg1) (54) . These results demonstrated the importance of COUP-TFs in skeletal muscle metabolism and, specifically, the importance of delineating the individual roles of COUP-TFI and COUP-TFII in skeletal muscle cells.
COUP-TFII mRNA is more abundantly expressed (than COUP-TFI mRNA) in skeletal muscle C2C12 cells and in (type I and II) skeletal muscle from C57BL/10 mice . Consequently, in this study we have utilized stable ectopic expression of COUP-TFII in C2C12 cells and TLDA analysis to investigate COUP-TFII gene targets in differentiated skeletal muscle cells. Using this approach we have demonstrated regulation of genes involved in myogenic differentiation and hypertrophy (Caveolin-3, Myostatin, MyoD, Akt, GR, AR, and Smad2) as well as genes involved in glucose utilization and storage (Glut4, PGC1␣, PPAR␥, Akt-1, glycogen synthase, and muscle glycogen phosphorylase). However, it is important to note that our system may reflect the COUP-TFII actions on gene expression during myoblast differentiation to myotubes, as the exogenous protein is downregulated in a differentiation-dependent manner.
The finding of our study that COUP-TFII regulates metabolic gene expression in C2C12 skeletal muscle cells is consistent with reports that demonstrate COUP-TFs activate the transcription of several metabolic genes, including CYP7A in liver cells (33, 73, 75) , CETP (20) , and PEPCK (6, 27, 67) . COUP-TFI represses the MCAD NRRE-1 in CV-1 cells (11), while siRNA-mediated attenuation of COUP-TFI and COUP-TFII in C2C12 cells led to mild (1.7-fold) repression of MCAD (54) .
Regulation of genes involved in differentiation and hypertrophy. The COUP-TFII-overexpressing cell lines in the current study demonstrated regulation of caveolin-3 and Akt-1, Smad 2 and 4, myostatin, myostatin receptor ACVR2A, glucocorticoid receptor (GR), and AR, genes that have interconnecting roles in regulation of differentiation and hypertrophy (4, 7, 9, 10, 14, 15, 16, 17, 19, 23, 32, 39, 40, 41, 43, 44, 47, 48, 52, 56, 71, 76) .
Of interest, the cell lines ectopically expressing the native mouse COUP-TFII displayed a 0.6-fold decrease in MyoD mRNA expression, as previously reported in Muscat et al. (53) with the human COUP-TFII (after 3 days of serum withdrawal). However, in the ectopic COUP-TFII-expressing cells, decreased MyoD expression in myotubes was not accompanied by decreased expression of myogenin, and no significant changes in mRNA expression of the differentiation markers myogenin or type I and II troponin I were seen in COUP-TFIItransfected cells compared with the pSG5 control transfected cells.
However, we did observe decreases in the myostatin pathway; for example, significant decreases in the expression of Acvr2a, myostatin, and Smad 2 and 4 were observed. Myostatin mRNA is upregulated during C2C12 differentiation (65) and is upregulated by SMAD2, -3, and 4, (2). Myostatin binds to Acvr2a though binding is higher to Acvr2b (43) . This suggests that the ectopic expression of COUP-TFII had differential and selective effects on different aspects of in vitro differentiation (e.g., Glut4 vs. myostatin). Muscat et al. (53) reported that myogenin mRNA expression was suppressed; however, the differences in the expression of this transcript may involve the length of serum withdrawal, and the differentiation-dependent downregulation of COUP-TFII during differentiation.
Modulation of genes involved in glucose utilization. Several genes involved in glucose utilization were regulated by ectopic COUP-TFII expression in C2C12 cells, including Glut4, PPAR␥, and PGC1␣. The insulin-responsive Glut4 mediates glucose uptake in response to insulin stimulation and is expressed in white and brown adipose tissue (30, 78), heart, and skeletal muscle (84) . Glut4 is the principle mediator of insulin stimulated glucose transport in muscle (83) and the regulation of Glut4 expression has been the focus of much study, due to its role in glucose uptake and whole body glucose homeostasis. Overexpression of Glut4 in muscle of genetically diabetic and high fat diet-fed mice alleviates insulin resistance and improves glycemic control (21) . Furthermore, in obese Zucker rats, improvement in muscle insulin resistance seen with exercise training was found to be dependent on increased Glut4 protein expression (31) . These findings indicate that an increase in muscle Glut4 expression may be useful in correcting insulin resistance. In our study, Glut4 mRNA and protein expression were increased in the COUP-TFII-overexpressing cells and downregulated in COUP-TFII⌬H12-transfected C2C12s, and this regulation was further investigated in this study using promoter assays and ChIP analysis. By ChIP assay we found that COUP-TFII binds the Ϫ223 to Ϫ23 region of the Glut4 promoter encompassing a highly conserved SP1 site, and mutation of this site abolished COUP-TFII-mediated transactivation of the Glut4 promoter in C2C12 cells. COUP-TFII has previously been shown to activate transcription through an Sp1 site (62) , and an Sp1 site has also been shown to be necessary for COUP-TFI repression and activation of transcription of target genes (12, 82) .
Glut4 expression is upregulated by PGC1 in skeletal muscle cells in vitro (49, 79) and in vivo (8) , by binding to and coactivating MEF2C (49) and PGC1␣ plays a role in oxidative metabolism and basal and insulin-stimulated glucose uptake (49, 63, 80) . PGC1␣ is downregulated in skeletal muscle in Type 2 diabetes (59) and polymorphisms in PGC1␣ are associated with increased risk of diabetes (46) . In the COUP-TFIIoverexpressing cells in the current study, PGC1␣ expression was induced, concomitant with the induction of Glut4 expression.
PPAR␥ expression was also repressed in COUP-TFII overexpressing C2C12s in the current study, and COUP-TFII has previously been shown to repress PPAR␥ expression in adipocytes (57) . PPAR␥ regulates adipocyte differentiation and fatty acid uptake and storage. The synthetic PPAR gamma agonists, the thiazolidinediones (TZDs) have an insulin-sensitizing effect and have been used successfully to treat insulin resistance in patients with Type 2 diabetes (18, 24, 42, 64) Interestingly, unliganded PPAR␥ associates with co-repressors and represses transcription of certain target genes (3, 26) , including Glut4, and the TZD rosiglitazone alleviates this repression (3) .
While the importance of PPAR␥ in adipose tissue and insulin sensitization has been well established (72) , its role in skeletal muscle is less clear. Studies with PPAR␥-deficient mice have given opposing results. One study has reported that the insulin-sensitizing effects of TZDs were not attenuated in skeletal muscle-specific PPAR␥ knockout mice, indicating that this effect was not mediated through muscle (55) , while another report showed that PPAR␥-deficient mice developed severe muscle insulin resistance that was not improved by TZDs (28) , suggesting that muscle PPAR␥ is the target for TZDs. It has also been shown that PPAR␥ expression is elevated in skeletal muscle of obese and Type II diabetic subjects and is regulated by insulin, indicating that PPAR␥ expression may plays a complex ole in skeletal muscle insulin resistance in obesity and diabetes (58). A: COUP-TFII trans-activates the native Glut4 promoter but not the mutated Glut4 promoter (Glut4m1) in C2C12 cells. C2C12 cells were cotransfected with 2.8 g of the pGL2-Glut4, pGL2-Glut4m1 promoters, or the pGL2 basic vector, and 0.2 g pSG5-COUP-TFII or pSG5 over 6 wells of a 24-well plate. Media were changed 24 h after transfection, and luciferase activities were determined in cell lysates 48 h after transfection. Data represent means Ϯ SE from 3 independent experiments. Statistical significance was measured using unpaired two-tailed Student's t-test where ***P Ͻ 0.0001. B: diagrammatic representation of the Glut4 promoter with predicted Sp1 sites and sites of primers used in ChIP analysis. C: COUP-TFII binds the Glut4 promoter in C2C12 cells. ChIP analysis showing fold enrichment of COUP-TFII binding relative to IgG at each site of the Glut4 promoter. Error bars represent SE from 3 independent experiments. Statistical significance was measured using unpaired two-tailed Student's t-test where ***P Ͻ 0.0001. D: mouse, human, and rat sequences of highly conserved Sp1 and SRE binding sites in site B of the Glut4 promoter. Mutations made to the mouse Glut4 promoter are shown in boldface and underlined.
As such, the repression of PPAR␥ mRNA and increased Glut4 and PGC1␣ expression with expression of ectopic COUP-TFII indicate that these cells may have improved glucose uptake and insulin sensitivity, which would be of interest to study in vivo, for example in mice expressing skeletal muscle-specific ectopic COUP-TFII.
Thus in the current study, ectopic expression of COUP-TFII led to gene changes that are in concordance with increased glucose utilization. The importance of many of these novel COUP-TFII gene targets in metabolism indicates that COUP-TFII may be an interesting target for research into novel therapeutics for metabolic disease and diabetes. With skeletal muscle accounting for the majority of insulin-stimulated glucose disposal (3), further research into the in vivo actions of COUP-TFII in skeletal muscle would be warranted.
